19 reports

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

The biologics are mainly derived from monoclonal antibodies, recombinant proteins, cell therapy, and others.

  • Surgery
  • World
  • Alphatec Spine, Inc.
  • Medtronic, Inc.
  • NuVasive, Inc.

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

Pancreatic cancer

4385 5000 3900

Yttrium-## clivatuzumab tetraxetan is a humanized monoclonal antibody labeled with radioisotope Yttrium-##.

  • Surgery
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • NewLink Genetics Corporation
  • Taiho Pharmaceutical Co., Ltd.

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cough And Cold
  • Therapy
  • United States
  • World
  • Product Initiative

Most recently she served as the Worldwide Brand Director at Novartis Pharmaceuticals Corporation, where she was the global launch lead for Aimovig®, the first monoclonal antibody approved by the U. S.

  • Clinical Trial
  • Cough And Cold
  • Surgery
  • United States
  • AcelRx Pharmaceuticals, Inc.

The drug candidate is a monoclonal antibody that inhibits binding of IL-## to the ST## receptor.

  • Cough And Cold
  • Surgery
  • Therapy
  • United States
  • Product Initiative

Phase ## A phase ## trial evaluatingSAR##, an anti-CD## monoclonal antibody, was initiated in multiple myeloma.

  • Clinical Trial
  • Cough And Cold
  • Hemostat
  • Surgery
  • Wound Care

CEMIPLIMAB IS AN INVESTIGATIONAL HUMAN, MONOCLONAL ANTIBODY TARGETING PD-##, BEING JOINTLY DEVELOPED BY SANOFI AND REGENERON.

  • Cough And Cold
  • Surgery
  • France
  • Western Europe
  • Sanofi S.A.

It also develops a product candidate, an anti-CD## monoclonal antibody that inhibits the production of adenosine produced by the tumor cells.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Vernalis plc

This collaboration combines AbbVie' s monoclonal antibody expertise, global clinical development and commercial capabilities with Voyager' s gene therapy platform and expertise that enables generating adeno-associated viral vectors for the treatment of neurodegenerative dis

  • Medical Device
  • Surgery
  • United States
  • Company
  • Boston Scientific Corporation

Cemiplimab is an investigational human, monoclonal antibody targeting PD-##, being jointly developed by Sanofi and Regeneron.

  • Clinical Trial
  • Cough And Cold
  • Hemostat
  • Surgery
  • Sanofi S.A.

Cemiplimab is an investigational human, monoclonal antibody targeting PD-##, being jointly developed by Sanofi and Regeneron.

  • Cough And Cold
  • Surgery
  • United States
  • Demand
  • Sanofi S.A.

This collaboration combines AbbVie' s monoclonal antibody expertise, global clinical development and commercial capabilities with Voyager' s gene therapy platform and expertise that enables generating adeno-associated viral vectors for the treatment of neurodegenerative dis

  • Cough And Cold
  • Surgery
  • Technical Textiles
  • United States
  • Viveve Medical, Inc.

SAR##, a maytansin-loaded anti-CA## monoclonal antibody, moved into Phase ## for the treatment of solid tumors.

  • Clinical Trial
  • Cough And Cold
  • Surgery
  • Wound Care
  • Sanofi S.A.

It is designed to detect C##a-receptors or complement component ##a receptor ## (C##AR##) specific to inflammatory diseases in patient' s samples using monoclonal antibodies.

  • Biomarker
  • Dementia
  • Genomics Proteomics And Enabling Technology
  • Surgery
  • Mirna Therapeutics, Inc.

The company" s product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer.

  • Anesthetics
  • Cough And Cold
  • Pharmaceutical
  • Surgery
  • Opiant Pharmaceuticals, Inc.

One unit refers to one reusable vitrectomy pack.

  • Surgery
  • Vitreoretinal Surgery Device
  • North America
  • Market Size
  • Valeant Pharmaceuticals International, Inc.

One unit refers to one reusable vitrectomy pack.

  • Health Services
  • Surgery
  • Canada
  • Market Size
  • Valeant Pharmaceuticals International, Inc.